Cambridge, MA, United States of America

Michael Storek

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Michael Storek: A Pioneer in Complement-Mediated Disease Treatments**

Introduction

Michael Storek is an innovative inventor based in Cambridge, MA, known for his significant contributions in the field of biotechnology. With a total of five patents to his name, he has made strides in developing novel methods of treating complement-mediated diseases through cutting-edge fusion protein constructs.

Latest Patents

Among his latest patents is a groundbreaking method of treating complement-mediated diseases using fusion protein constructs that consist of an anti-C3d antibody and a complement modulator. These constructs are designed to bind to complement-associated antigens, which involves a targeting moiety such as an antibody or its binding fragment. This invention provides new avenues for addressing conditions mediated by the complement system. Another notable patent features fusion protein constructs comprising both the anti-C3d antibody and a CR1 polypeptide, further expanding his innovative approaches in treating complement mediation conditions.

Career Highlights

Michael Storek has an impressive professional background, having worked with reputable companies such as Q32 Bio Inc. and Monsanto Technology LLC. His experience in these organizations has allowed him to collaborate on various research projects and expand his expertise in biotechnology and pharmaceuticals.

Collaborations

Throughout his career, Storek has had the opportunity to work alongside talented individuals, such as Michael Steven Curtis and Shelia Marie Violette. These collaborations have enriched his research and played a role in the successful development of his patented innovations.

Conclusion

Michael Storek's work in the realm of complement-mediated diseases reflects the innovative spirit needed to address complex medical conditions. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for advancements in the life sciences, promising new treatment options for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…